Equities

Shanghai Haixin Group Co Ltd

Shanghai Haixin Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.83
  • Today's Change0.03 / 0.63%
  • Shares traded10.71m
  • 1 Year change-28.55%
  • Beta1.0819
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments686715561
Total Receivables, Net175214215
Total Inventory859097
Prepaid expenses246941
Other current assets, total24----
Total current assets9941,088913
Property, plant & equipment, net468453530
Goodwill, net------
Intangibles, net132424
Long term investments3,4063,3373,829
Note receivable - long term------
Other long term assets------
Total assets4,9114,9305,326
LIABILITIES
Accounts payable407886
Accrued expenses6811489
Notes payable/short-term debt766585
Current portion long-term debt/capital leases0.011.631.99
Other current liabilities, total147215219
Total current liabilities330472481
Total long term debt12121.05
Total debt887888
Deferred income tax433427561
Minority interest170175154
Other liabilities, total------
Total liabilities9461,0861,197
SHAREHOLDERS EQUITY
Common stock1,2071,2071,207
Additional paid-in capital420420420
Retained earnings (accumulated deficit)1,3611,2501,123
Treasury stock - common------
Unrealized gain (loss)1,0039941,405
Other equity, total(27)(27)(26)
Total equity3,9653,8444,128
Total liabilities & shareholders' equity4,9114,9305,326
Total common shares outstanding1,2071,2071,207
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.